Side Effects of Biologic and Immunologic Therapies of Pediatric Cancer Management
摘要
Targeted therapies, including biologics and immunologics are being used more frequently in pediatric malignancies. While these agents may be better tolerated than conventional chemotherapy due to their targeted mechanisms of action, there are adverse effects associated with these agents. Clinicians caring for patients need to be able to recognize the adverse effects and provide prompt treatment to the patient.